Synthesis of novel diazabicycles and their antiprotozoal activities (Publications)
potencies against Plasmodium falciparum K-1 and Trypanosoma b. rhodesiense, the causative organisms of malaria tropica and the East African form of sleeping sickness
Public and Global Health Short Courses |Study at Swiss TPH (Page)
https://www.swisstph.ch/en/study-with-us/postgraduate/public-and-global-health-short-courses
information Online 5 weeks Field Malaria Course in Tanzania and Laos Enhance your capacity and expertise in malaria control and research to effectively address and manage malaria issues. Location Duration More [...] Resistant Mosquito: Staying Ahead of the Game in the Fight against Malaria (MOOC) Discover approaches and advances in our fight against the malaria mosquito using Insecticide Resistance Management (IRM). Location [...] cover a range of global and public health topics such as...
Health Impact Assessment (HIA) | Services at Swiss TPH (Page)
https://www.swisstph.ch/en/services/health-impact-assessment
Read more Scoping study on gene drive use in malaria-transmitting mosquitoes in West Africa Genetically modified mosquitoes have great potential for malaria control. Together with the University of Liverpool [...] mosquito releases, raise awareness of genetic control tools for malaria among policy makers, and review regulatory frameworks for malaria control and genetically modified organisms in 15 West African countries [...] potential use of Anopheles mosquitoes containing a gene drive...
Incorporation of an intramolecular hydrogen bonding motif in the side chain of antimalarial benzimidazoles (Publications)
activity against chloroquine-sensitive (NF54) and multi-drug resistant (K1) strains of the human malaria parasite Plasmodium falciparum. Compounds were also screened for their cytotoxicity towards a mammalian
Jonathan L. Vennerstrom: I was standing on the shoulders of giants (Publications)
collaborations with the Swiss Tropical and Public Health Institute (Swiss TPH) and the Medicines for Malaria Venture (MMV) have paved the way for antimalarial and antischistosomal drugs. In recognition of his
Jonathan L. Vennerstrom: I was standing on the shoulders of giants (Publications)
collaborations with the Swiss Tropical and Public Health Institute (Swiss TPH) and the Medicines for Malaria Venture (MMV) have paved the way for antimalarial and antischistosomal drugs. In recognition of his
Incorporation of an intramolecular hydrogen bonding motif in the side chain of antimalarial benzimidazoles (Publications)
activity against chloroquine-sensitive (NF54) and multi-drug resistant (K1) strains of the human malaria parasite Plasmodium falciparum. Compounds were also screened for their cytotoxicity towards a mammalian
New 4-amino-2-azabicyclo[3.2.2]nonane derivatives and their antiprotozoal potencies (Publications)
East African sleeping sickness, Trypanosoma b. rhodesiense, and a protozoan parasite which causes Malaria tropica, Plasmodium falciparum K-1, a strain which is resistant to chloroquine and pyrimethamine
Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort (Publications)
s in early pregnancy. They are, therefore, not recommended by WHO as a first-line treatment for malaria in first trimester due to associated embryo-foetal toxicity in animal studies. The study assessed
New 4-amino-2-azabicyclo[3.2.2]nonane derivatives and their antiprotozoal potencies (Publications)
East African sleeping sickness, Trypanosoma b. rhodesiense, and a protozoan parasite which causes Malaria tropica, Plasmodium falciparum K-1, a strain which is resistant to chloroquine and pyrimethamine
